Recent Posts

Entries Tagged: ‘life sciences


Pharmaceutical Translation & Global Drug Market

July 18th, 2011 | No Comments »

The need for pharmaceutical translation to tap into global drug markets isn’t news. But sales and growth forecasts for 2011 indicate that translations for China and other emerging markets will become more important than ever. IMS health (a pharmaceutical industry data company) predicts that the global drug market will grow 5 to 7% in 2011,



BIO Convention

June 29th, 2011 | No Comments »

Morningside is @ the 2011 BIO International Convention. If you haven’t worked with us yet and would like to learn more about our medical translation and patent translation services for the life sciences industry, this is an excellent opportunity to connect. Look for us in Booth 3053. You might even win an iPad 2!



BIO Preview: Translations & The Biotechnology Industry

June 23rd, 2011 | 1 Comment »

The BIO International Convention takes place next week in Washington, DC and Morningside will be attending (our 4th year in a row). We thought it would be timely to provide an overview on how medical translations are used by biotech companies. The need for translations can come up throughout a product’s life cycle–from R&D, to



Translating for Life Sciences

October 7th, 2010 | No Comments »

The life sciences industry – which includes pharmaceutical, medical device, and healthcare companies – is truly a global business. For many industry leaders, the lion’s share of revenue comes from overseas markets. Whether you are working to secure IP rights in Japan or obtain regulatory approval in the EU, translating documents for multiple countries and jurisdictions is an intrinsic part of the process. Patent applications, clinical trial reports, labeling, patent applications, regulatory submissions, and product manuals are just a few examples of documents that have to be translated by life sciences companies on a regular basis.